Last edition
News about "Glenmark Pharma receives US FDA approval for theop"
Glenmark Pharma receives US FDA approval for theophylline ER tablets
Glenmark Pharmaceuticals Limited (Glenmark) has received final approval from the United States Food & Drug Administration (FDA) for theophylline extended release tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent to the reference listed drug, theophylline extended release tablets, 300 mg and 450 mg, of Alembic Pharmaceuticals Lmt
Glenmark Pharma Receives US FDA Approval For Theop | 04/06/2021 | By Darshana | 212
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy